Igors Ivanovs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Igors Ivanovs has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anna Marija Lescinska
Institute of Clinical and Preventive Medicine, Faculty of Medicine and Life Sciences, University of Latvia (UL), 1586 Riga, Latvia
1 shared publication - Armands Sivins
Institute of Clinical and Preventive Medicine, University of Latvia, LV-1079 Riga, Latvia
1 shared publication Biruta Mamaja
Department of Anesthesiology , Rīga East University Hospital , Rīga Latvia
1 shared publication- Elizabete Folkmane
Faculty of Medicine, University of Latvia, LV-1004 Riga, Latvia
1 shared publication - Evelina Merdane
Faculty of Medicine, University of Latvia, LV-1004 Riga, Latvia
1 shared publication - Gidi Shani
Laboratory for Nanomaterial-Based Devices, Technion—Israel Institute of Technology, Haifa 3200003, Israel
1 shared publication
Latest Publications
- Open Access
- 1 June 2023
- Published by IntechOpen
Hiatal Hernia Surgery
Hiatal hernia is a protrusion of abdominal organs through enlarged esophageal hiatus. Hiatal hernia is a relatively common pathology but, in most cases, it remains asymptomatic. Four types of hiatal hernia exist. Type I or sliding hernia, type II or true paraesophageal hernia, type III or mixed hernia and type IV or giant hernia. Diagnosis of hiatal hernia usually is done by upper endoscopy and upper gastrointestinal (GI) barium examination. Treatment of hiatal hernia type I coincides with concomitant gastroesophageal reflux treatment, while treatment of hiatal hernia type II, III and IV is mainly surgical. The surgical approach to repair hiatal hernia could be either transabdominal or transthoracic. Currently, laparoscopy is the best method for hiatal hernia repair. Surgery consists of two main steps: hiatal hernia plasty and fundoplication. Despite modern technologies the recurrence rate in large hiatal hernia repair remains high, therefore reinforcement of the diaphragm withmesh is recommended. There are controversies about the materials and techniques used.
- 1 June 2023
- Published by IntechOpen
Open AccessHiatal Hernia Surgery
Hiatal hernia is a protrusion of abdominal organs through enlarged esophageal hiatus. Hiatal hernia is a relatively common pathology but, in most cases, it remains asymptomatic. Four types of hiatal hernia exist. Type I or sliding hernia, type II or true paraesophageal hernia, type III or mixed hernia and type IV or giant hernia. Diagnosis of hiatal hernia usually is done by upper endoscopy and upper gastrointestinal (GI) barium examination. Treatment of hiatal hernia type I coincides with concomitant gastroesophageal reflux treatment, while treatment of hiatal hernia type II, III and IV is mainly surgical. The surgical approach to repair hiatal hernia could be either transabdominal or transthoracic. Currently, laparoscopy is the best method for hiatal hernia repair. Surgery consists of two main steps: hiatal hernia plasty and fundoplication. Despite modern technologies the recurrence rate in large hiatal hernia repair remains high, therefore reinforcement of the diaphragm withmesh is recommended. There are controversies about the materials and techniques used.
- Open Access
- 1 April 2022
- Published by Walter de Gruyter GmbH in Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
- Vol. 76 (2) , 225-231
Efficiency of Retromuscular Rectus Sheath Block with Continuous Bupivacaine Catheter Infusion After Open Gastrectomy
Severe pain is a major problem in the early postoperative period after open major upper gastrointestinal surgery. This study aimed to assess the efficiency of rectus sheath block with catheters placed through open access into the retromuscular space in providing effective pain relief. A prospective study was done at Rīga East University Hospital, Latvia. Thirty-nine patients with open gastrectomy were allocated into two groups: 21 patients in the block group and 18 patients in the control group. In the block group, at the end of the operation, two catheters were inserted into the retromuscular plane under the m. rectus abdominis through the open access (using a specially invented technique). After surgery, patients in the block group received continuous 0.125% (10–12 mg/h) bupivacaine infusion through rectus sheath catheters for 72 hours. Patients in the control group received standard postoperative analgaesia. The results showed that postoperative pain at rest was significantly lower in the Block group than in the control group at 48-hour and 72-hour intervals after surgery. Pain on movement in the block group was significantly lower than that in the control group at all postoperative times: at 24, 48, and 72 hours. The median fentanyl requirement range in the postoperative period was significantly lower in the block group (0.5 (0–1.25) mg) than in the control group (2.0 (1.0–3.25) mg (p = 0.001)). Continuous retromuscular rectus sheath infiltration of 0.125% bupivacaine through a rectus sheath catheter after open gastrectomy provides effective postoperative analgaesia in the early postoperative period and significantly reduces opioid consumption.
- 1 April 2022
- Published by Walter de Gruyter GmbH in Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
- Vol. 76 (2) , 225-231
Open AccessEfficiency of Retromuscular Rectus Sheath Block with Continuous Bupivacaine Catheter Infusion After Open Gastrectomy
Severe pain is a major problem in the early postoperative period after open major upper gastrointestinal surgery. This study aimed to assess the efficiency of rectus sheath block with catheters placed through open access into the retromuscular space in providing effective pain relief. A prospective study was done at Rīga East University Hospital, Latvia. Thirty-nine patients with open gastrectomy were allocated into two groups: 21 patients in the block group and 18 patients in the control group. In the block group, at the end of the operation, two catheters were inserted into the retromuscular plane under the m. rectus abdominis through the open access (using a specially invented technique). After surgery, patients in the block group received continuous 0.125% (10–12 mg/h) bupivacaine infusion through rectus sheath catheters for 72 hours. Patients in the control group received standard postoperative analgaesia. The results showed that postoperative pain at rest was significantly lower in the Block group than in the control group at 48-hour and 72-hour intervals after surgery. Pain on movement in the block group was significantly lower than that in the control group at all postoperative times: at 24, 48, and 72 hours. The median fentanyl requirement range in the postoperative period was significantly lower in the block group (0.5 (0–1.25) mg) than in the control group (2.0 (1.0–3.25) mg (p = 0.001)). Continuous retromuscular rectus sheath infiltration of 0.125% bupivacaine through a rectus sheath catheter after open gastrectomy provides effective postoperative analgaesia in the early postoperative period and significantly reduces opioid consumption.
- Open Access
- 14 February 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 491
Modular Point-of-Care Breath Analyzer and Shape Taxonomy-Based Machine Learning for Gastric Cancer Detection
Background: Gastric cancer is one of the deadliest malignant diseases, and the non-invasive screening and diagnostics options for it are limited. In this article, we present a multi-modular device for breath analysis coupled with a machine learning approach for the detection of cancer-specific breath from the shapes of sensor response curves (taxonomies of clusters). Methods: We analyzed the breaths of 54 gastric cancer patients and 85 control group participants. The analysis was carried out using a breath analyzer with gold nanoparticle and metal oxide sensors. The response of the sensors was analyzed on the basis of the curve shapes and other features commonly used for comparison. These features were then used to train machine learning models using Naïve Bayes classifiers, Support Vector Machines and Random Forests. Results: The accuracy of the trained models reached 77.8% (sensitivity: up to 66.54%; specificity: up to 92.39%). The use of the proposed shape-based features improved the accuracy in most cases, especially the overall accuracy and sensitivity. Conclusions: The results show that this point-of-care breath analyzer and data analysis approach constitute a promising combination for the detection of gastric cancer-specific breath. The cluster taxonomy-based sensor reaction curve representation improved the results, and could be used in other similar applications.
- 14 February 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 491
Open AccessModular Point-of-Care Breath Analyzer and Shape Taxonomy-Based Machine Learning for Gastric Cancer Detection
Background: Gastric cancer is one of the deadliest malignant diseases, and the non-invasive screening and diagnostics options for it are limited. In this article, we present a multi-modular device for breath analysis coupled with a machine learning approach for the detection of cancer-specific breath from the shapes of sensor response curves (taxonomies of clusters). Methods: We analyzed the breaths of 54 gastric cancer patients and 85 control group participants. The analysis was carried out using a breath analyzer with gold nanoparticle and metal oxide sensors. The response of the sensors was analyzed on the basis of the curve shapes and other features commonly used for comparison. These features were then used to train machine learning models using Naïve Bayes classifiers, Support Vector Machines and Random Forests. Results: The accuracy of the trained models reached 77.8% (sensitivity: up to 66.54%; specificity: up to 92.39%). The use of the proposed shape-based features improved the accuracy in most cases, especially the overall accuracy and sensitivity. Conclusions: The results show that this point-of-care breath analyzer and data analysis approach constitute a promising combination for the detection of gastric cancer-specific breath. The cluster taxonomy-based sensor reaction curve representation improved the results, and could be used in other similar applications.
- Open Access
- 24 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 287
Clinicopathological Significance of Exosomal Proteins CD9 and CD63 and DNA Mismatch Repair Proteins in Prostate Adenocarcinoma and Benign Hyperplasia
Introduction. Recently, it has been shown that exosomal biomarkers and DNA mismatch repair proteins (MMR) could play an important role in cancer risk stratification and prognosis assessment. The gold standard for prostate carcinoma (PCa) diagnosis is biopsy and histopathological examination. Thus, the complex evaluation of exosomal and MMR proteins could be beneficial for prostate cancer risk stratification and diagnostics. The aim of the current study was to evaluate and compare the expression of exosomal proteins CD9 and CD63 and MMR proteins in the tissue of patients with prostate benign hyperplasia (BPH) and PCa. Methods. The study was retrospective. Altogether, 92 patients with PCa and 20 patients with BPH (control group) were enrolled in the study. Exosomal and MMR protein expression was analyzed by immunohistochemistry (IHC). The follow-up for each PCa patient in our study lasted till disease progression and/or a maximum of 5 years. Results. Low-grade PCa was observed in 56 patients and high-grade PCa in 36 patients. CD63 expression was significantly higher in patients with high-grade PCa compared to those with low-grade PCa. CD9 expression was significantly downregulated in PCa patients compared to the control group. MMR protein expression deficiency was observed in 10 PCa patients. MMR proteins were maintained in all cases of BPH. The study found a negative correlation between MMR protein loss and PCa ISUP grade groups. Progression-free survival (PFS) in patients with MMR deficiency was significantly shorter than in patients with maintained MMR expression. Conclusions. CD9 protein expression was downregulated in PCa, compared to BPH, while CD63 protein expression was upregulated in high-grade PCa but downregulated in low-grade PCa. CD63 protein upregulation, CD9 downregulation, and loss of MMR protein characterized the shorter PFS of high-grade PCa patients. CD9, CD63, and MMR could be the routine immunohistochemical biomarkers for the diagnosis and risk stratification of PCa.
- 24 January 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (2) , 287
Open AccessClinicopathological Significance of Exosomal Proteins CD9 and CD63 and DNA Mismatch Repair Proteins in Prostate Adenocarcinoma and Benign Hyperplasia
Introduction. Recently, it has been shown that exosomal biomarkers and DNA mismatch repair proteins (MMR) could play an important role in cancer risk stratification and prognosis assessment. The gold standard for prostate carcinoma (PCa) diagnosis is biopsy and histopathological examination. Thus, the complex evaluation of exosomal and MMR proteins could be beneficial for prostate cancer risk stratification and diagnostics. The aim of the current study was to evaluate and compare the expression of exosomal proteins CD9 and CD63 and MMR proteins in the tissue of patients with prostate benign hyperplasia (BPH) and PCa. Methods. The study was retrospective. Altogether, 92 patients with PCa and 20 patients with BPH (control group) were enrolled in the study. Exosomal and MMR protein expression was analyzed by immunohistochemistry (IHC). The follow-up for each PCa patient in our study lasted till disease progression and/or a maximum of 5 years. Results. Low-grade PCa was observed in 56 patients and high-grade PCa in 36 patients. CD63 expression was significantly higher in patients with high-grade PCa compared to those with low-grade PCa. CD9 expression was significantly downregulated in PCa patients compared to the control group. MMR protein expression deficiency was observed in 10 PCa patients. MMR proteins were maintained in all cases of BPH. The study found a negative correlation between MMR protein loss and PCa ISUP grade groups. Progression-free survival (PFS) in patients with MMR deficiency was significantly shorter than in patients with maintained MMR expression. Conclusions. CD9 protein expression was downregulated in PCa, compared to BPH, while CD63 protein expression was upregulated in high-grade PCa but downregulated in low-grade PCa. CD63 protein upregulation, CD9 downregulation, and loss of MMR protein characterized the shorter PFS of high-grade PCa patients. CD9, CD63, and MMR could be the routine immunohistochemical biomarkers for the diagnosis and risk stratification of PCa.